| DF | decapacitation factor; decontamination factor; deferoxamine; deficiency factor; defined flora [anima... |
|---|---|
| DFO, DFOM | deferoxamine |
| DIT | deferoxamine infusion test; diet-induced thermogenesis; diiodotyrosine; drug-induced thrombocytopeni... |
| DF | Deferoxamine |
|---|---|
| DFO | Deferoxamine |
| DFX | Deferoxamine |
| DFO | Deferoxamine mesylate |
| deferoxamine | <chemical> Natural product isolated from streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the form of its mesylate. Because of its ability to form nonabsorbable and rapidly excretable complexes with iron, it is effective in the treatment of conditions associated with excessive iron storage and iron poisoning. Pharmacological action: antidotes. Chemical name: Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy- (12 Dec 1998) |
|---|---|
| deferoxamine mesylate | Methanesulfonate of 30-amino-3,14,25-trihydroxy-3,9,14,20,25-penta-azatriacontane-2,10,13,21,24-pentaone;chelate used in the treatment of iron poisoning. Synonym: desferrioxamine mesylate. (05 Mar 2000) |
Synonyms : Deferoxamine B, Deferoxamine Mesilate, Deferoxamine Mesylate, Deferoxamine Methanesulfonate, Deferoximine, Deferrioxamine B, Desferal, Desferioximine, Desferrioxamine B, Desferrioxamine B Mesylate, Desferroxamine, B, Deferoxamine, B, Desferrioxamine
| deferoxamine |
Iron-chelating agent used therapeutically to treat acute iron intoxication or chronic iron overload in transfusion-dependent patients. May also be used to treat hemochromatosis in patients such as anemics who cannot tolerate phlebotomy. It forms a water-soluble complex with iron that is excreted in urine and feces (see chelation therapy).
출처: www.cdc.gov/hemochromatosis/training/glossary.htm
|
|---|---|
| deferoxamine |
A drug used in iron intoxication, chronic iron overload after multiple blood transfusions and hemochromatosis, if phebotomies are not possible. An investigational use is treatment of aluminium overload in renal failure. Registered trade mark in USA Desferal.
출처: www.gastrolab.net/dicted.htm
|
| deferoxamine |
An iron-chelating agent that removes iron from tumors by inhibiting DNA synthesis and causing cancer cell death. It is used in conjunction with other anticancer agents in pediatric neuroblastoma therapy.
출처: www.seniormag.com/conditions/cancer/cancerglossary...
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
